| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |